HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $81,314 | -32.6% | 2,129,204 | +0.4% | 0.14% | -41.7% |
Q4 2022 | $120,660 | -99.9% | 2,120,571 | -1.3% | 0.24% | +40.7% |
Q3 2022 | $84,943,000 | -11.1% | 2,148,273 | -1.1% | 0.17% | -2.8% |
Q2 2022 | $95,590,000 | +9.7% | 2,172,478 | -0.6% | 0.18% | +52.6% |
Q1 2022 | $87,149,000 | +12.4% | 2,185,274 | +13.4% | 0.12% | +23.4% |
Q4 2021 | $77,514,000 | -3.3% | 1,927,738 | -2.1% | 0.09% | -5.1% |
Q3 2021 | $80,141,000 | -10.6% | 1,970,055 | -0.3% | 0.10% | -9.2% |
Q2 2021 | $89,693,000 | +8.6% | 1,975,194 | -0.3% | 0.11% | +1.9% |
Q1 2021 | $82,599,000 | -2.6% | 1,981,256 | -0.2% | 0.11% | -4.5% |
Q4 2020 | $84,781,000 | +123.0% | 1,985,026 | +37.2% | 0.11% | +103.6% |
Q3 2020 | $38,024,000 | -0.1% | 1,446,855 | +1.9% | 0.06% | -9.8% |
Q2 2020 | $38,052,000 | +63.2% | 1,419,336 | +9.5% | 0.06% | +27.1% |
Q1 2020 | $23,315,000 | +2.1% | 1,296,003 | +0.6% | 0.05% | +23.1% |
Q4 2019 | $22,835,000 | +13.9% | 1,287,945 | -0.3% | 0.04% | 0.0% |
Q3 2019 | $20,041,000 | – | 1,292,163 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
2Xideas AG | 416,586 | $23,703,743 | 2.51% |
Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |